| Bioactivity | Atovaquone-d4 is the deuterium labeled Atovaquone. Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia[1]. |
| Name | Atovaquone-d4 |
| CAS | 2070015-14-2 |
| Formula | C22H15D4ClO3 |
| Molar Mass | 370.86 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Looareesuwan, S., et al., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996. 54(1): p. 62-6. |
Atovaquone-d4
CAS: 2070015-14-2 F: C22H15D4ClO3 W: 370.86
Atovaquone-d4 is the deuterium labeled Atovaquone.Atovaquone is a medication used to treat or prevent for pneumocystis
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.